Exponent
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 2 months.
- Recent price momentum is +30.7% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has fallen to 5.1% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation C-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 38.4x | Better than 14% |
| Forward P/E | 32.9x | Better than 15% |
| Price / Sales | 6.3x | Better than 17% |
| P/E vs own 5-yr range | 31st pctl | Better than 76% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 4.3% | Better than 44% |
| Net income CAGR (3Y) | 1.2% | Better than 43% |
| Free cash flow CAGR (3Y) | 14.4% | Better than 59% |
Profitability A-
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 33.0% | Better than 37% |
| Operating margin | 20.6% | Better than 78% |
| Net margin | 18.2% | Better than 76% |
| Return on equity | 26.1% | Better than 85% |
| Return on invested capital | 20.4% | Better than 90% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 27.6% | Better than 98% |
| 6-month return | 55.8% | Better than 96% |
| 12-month return (ex latest month) | 11.6% | Better than 49% |
| Distance below 52-week high | 2.0% | Better than 98% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.4x | Better than 64% |
| Debt to assets | 10.7% | Better than 68% |
| Interest coverage | 54,820.0x | Better than 100% |
| Free cash flow / net income | 115.4% | Better than 49% |
Analyst View C-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 75.0% | Better than 51% |
| Upside to average target | 1.7% | Better than 5% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 89.00
- Open
- 89.05
- Day range
- 89.04 - 90.98
- Avg price
- 89.80
- Volume
- 534.14K
- Turnover
- 47.97M
- Turnover ratei
- 1.14%
- Volume ratioi
- 1.34
- Amplitudei
- 2.17%
- 52-week rangei
- 51.41 - 90.98
Valuation
- P/Ei
- 43.07
- P/E (TTM)i
- 38.43
- P/Bi
- 13.77
- EPSi
- 2.07
- Book value / shi
- 6.48
- Net profit
- 98.43M
- Net assets
- 307.90M
Share structure
- Market cap
- 4.24B
- Float capi
- 4.18B
- Shares out
- 47.55M
- Float sharesi
- 46.91M
Dividend & listing
- Div yield (TTM)i
- 1.38%
- Dividend (TTM)
- 1.23
- Listing date
- 1970-01-01
2.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.12M net over the window
Short interest
- Shares short
- 2.42M
- % of floati
- 5.09%
- Days to coveri
- 4.04
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Exponent (EXPO)?
Exponent last traded at 89.16. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Exponent's market cap?
About 4.24B.
What is the P/E ratio of Exponent?
The trailing twelve-month P/E is 38.43, below its own 5-year average of 43.50 — toward the bottom of its historical range (30.86% percentile). See the Valuation tab for the full history.
Does Exponent pay a dividend?
Yes. The trailing dividend yield is 1.38%. The 2025 payout was up 7.1% from 2024. See the Dividends tab for the full payment history.
Is Exponent a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 90.67, which implies 1.7% upside from the current price. This is not investment advice.
What is Exponent's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Exponent a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Exponent discussion 0 comments